Use of modulators of the signal transduction pathway via the protein kinase fyn in the treatment of tumor diseases

摘要

The present invention describes the use of modulators of the signal transduction pathway via the protein kinase Fyn (e.g. Rho-kinase inhibitors or inhibitors of the protein kinase CSK) in the treatment of tumour diseases, especially in the therapy of neuroblastoma.